Audited Financial Results along with Audit Report thereon for the quarter and year ended on 31st March,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited reported audited results for FY25 showing revenue from operations of ₹241.43 lakhs, a sharp jump from just ₹2.24 lakhs in FY24. The company swung from a net loss of ₹26.41 lakhs in FY24 to a net profit of ₹16.39 lakhs in FY25, with EPS of ₹0.47 versus ₹(0.76) previously. However, the statutory auditor (Maak & Associates) issued a Qualified Opinion because balance confirmations were not provided for trade receivables (₹251.75 lakhs) and trade payables (₹363.28 lakhs). The company also disclosed serious balance-sheet stress: accumulated losses of ₹361.74 lakhs have wiped out its ₹346.59 lakhs paid-up capital, leaving negative net worth of ₹(15.15) lakhs, and current liabilities exceed current assets. Operating cash flow was negative at ₹(36.17) lakhs in FY25.
The headline swing to profit looks positive but is overshadowed by a qualified audit report, negative net worth, and going-concern flags. Shareholders should treat the profit figure with caution since it is unaudited at the confirmation level for key receivables/payables, and the company's solvency position remains weak.